Loading insider details...
Beta
Latest Form 4 (Jul 24, 2026): Sale of 6,798 IMVT shares, $263.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 24, 2026 | Immunovant, Inc. (IMVT) | Sale | 6,798 | $263.0K |
| Jun 26, 2026 | Immunovant, Inc. (IMVT) | Exercise/Conversion | 10,000 | $159.0K |
| Apr 24, 2026 | Immunovant, Inc. (IMVT) | Sale | 25,760 | $763.0K |
| Apr 9, 2026 | Immunovant, Inc. (IMVT) | Grant/Award | 64,968 | n/a |
| May 5, 2025 | Immunovant, Inc. (IMVT) | Grant/Award | 208,388 | n/a |
| May 23, 2024 | Landos Biopharma, Inc. (LABP) | Disposition to Issuer | 1,800 | n/a |